Concepedia

Maggie Liu

ML

Statistics

Publications

4

Citations

338

H-Index

4

Active since

1987

Affiliations

Pfizer (United States)(Current)

Maggie Liu is an author at Pfizer (United States) specializing in pharmacology, clinical pharmacology, and pharmacy.

Publications per year

1987–2023

4

Publications

4

Current nonclinical testing paradigm enables safe entry to First-In-Human clinical trials: The IQ consortium nonclinical to clinical translational database

Thomas M. Monticello, Thomas W. Jones, Donna M. Dambach et al. · Toxicology and Applied Pharmacology · 2017 · 177 citations

, , +10

Climate Change and Labor Reallocation: Evidence from Six Decades of the Indian Census

Maggie Liu, Yogita Shamdasani, Vis Taraz · American Economic Journal Economic Policy · 2023 · 85 citations · Full text

, , +17

Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: Rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure

Teresa De Marco, Paul Daly, Maggie Liu et al. · Journal of the American College of Cardiology · 1987 · 59 citations

, , +13

Comprehensive Nonclinical Safety Assessment of Nirmatrelvir Supporting Timely Development of the SARS-COV-2 Antiviral Therapeutic, Paxlovid™

Jean G. Sathish, Siddhartha Bhatt, Jamie K. DaSilva et al. · International Journal of Toxicology · 2022 · 17 citations · Full text

, , +16

1–4 of 4